Effect of communicating genetic and phenotypic risk for type 2 diabetes in combination with lifestyle advice on objectively measured physical activity: Protocol of a randomised controlled trial

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Godino, Job G ^a   Van Sluijs, Esther M F ^a   Marteau, Theresa M ^b   Sutton, Stephen ^b   Sharp, Stephen J ^a   Griffin, Simon J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Behaviour; Communication; Genetic; Phenotypic; Physical activity; Protocol; Randomised controlled trial; Risk; Type 2 diabetes

Indexed keywords

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; FOLLOW UP; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETICS; HEALTH BEHAVIOR; HEALTH CARE QUALITY; HUMAN; INTERPERSONAL COMMUNICATION; LIFESTYLE; METHODOLOGY; MOTOR ACTIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION;

ADULT; COMMUNICATION; DIABETES MELLITUS, TYPE 2; DIET; FOLLOW-UP STUDIES; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; MOTOR ACTIVITY; PHENOTYPE; PROGRAM EVALUATION; RISK REDUCTION BEHAVIOR;

EID: 84868537552     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-444     Document Type: Article

References (94)

1. Petit WA, Adamec CA, The encyclopedia of diabetes Facts On File, New York 2011
2. Type 2 diabetes prevention: a review. Ahmad LA, Crandall JP, Clin Diabetes 2010 28 53 59 10.2337/diaclin.28.2.53
3. Genes, environment, and interactions in prevention of type 2 diabetes: a focus on physical activity and lifestyle changes. Qi L, Hu FB, Hu G, Curr Mol Med 2008 8 519 532 10.2174/156652408785747915 18781959
4. The emerging genetic architecture of type 2 diabetes. Doria A, Patti ME, Kahn CR, Cell Metab 2008 8 186 200 10.1016/j.cmet.2008.08.006 18762020
5. The emerging genetics of type 2 diabetes. Bonnefond A, Froguel P, Vaxillaire M, Trends Mol Med 2010 16 407 416 10.1016/j.molmed.2010.06.004 20728409
6. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL, et al. Nat Genet 2010 42 105 116 10.1038/ng.520 20081858
7. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Lyssenko V, Nagorny CLF, Erdos MR, Wierup N, Jonsson A, Spegel P, Bugliani M, Saxena R, Fex M, Pulizzi N, et al. Nat Genet 2009 41 82 88 10.1038/ng.288 19060908
8. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PIW, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ, et al. Science 2007 316 1331 1336 17463246 (Pubitemid 46871653)
9. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, Walters GB, Styrkarsdottir U, Gretarsdottir S, Emilsson V, Ghosh S, et al. Nat Genet 2007 39 770 775 10.1038/ng2043 17460697 (Pubitemid 46848592)
10. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, et al. Nat Genet 2010 42 579 589 10.1038/ng.609 20581827
11. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, Hu T, de Bakker PIW, Abecasis GR, Almgren P, Andersen G, et al. Nat Genet 2008 40 638 645 10.1038/ng.120 18372903 (Pubitemid 351601209)
12. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, Timpson NJ, Perry JRB, Rayner NW, Freathy RM, et al. Science 2007 316 1336 1341 10.1126/science.1142364 17463249 (Pubitemid 46871654)
13. A vision for the future of genomics research: A blueprint for the genomic era. Collins FS, Green ED, Guttmacher AE, Guyer MS, Nature 2003 422 835 847 10.1038/nature01626 12695777 (Pubitemid 36520032)
14. Genetic architecture of type 2 diabetes: Recent progress and clinical implications. Grant RW, Moore AF, Florez JC, Diabetes Care 2009 32 1107 1114 10.2337/dc08-2171 19460916
15. Clinical translation of genetic predictors for type 2 diabetes. Majithia AR, Florez JC, Curr Opin Endocrinol Diabetes and Obesity 2009 16 100 106 10.1097/MED.0b013e3283292354
16. Genomics of type 2 diabetes mellitus: implications for the clinician. Stolerman ES, Florez JC, Nat Rev Endocrinol 2009 5 429 436 10.1038/nrendo.2009. 129 19564886
17. Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Buijsse B, Simmons RK, Griffin SJ, Schulze MB, Epidemiologic Rev 2011 33 46 62 10.1093/epirev/mxq019
18. Risk models and scores for type 2 diabetes: systematic review. Noble D, Mathur R, Dent T, Meads C, Greenhalgh T, Br Med J 2011 343 7163 10.1136/bmj.d7163
19. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. Talmud PJ, Hingorani AD, Cooper JA, Marmot MG, Brunner EJ, Kumari M, Kivimäki M, Humphries SE, Br Med J 2010 340 4838 10.1136/bmj.b4838
20. A practical guide to interpretation and clinical application of personal genomic screening. Edelman E, Eng C, Br Med J 2009 339 4253 10.1136/bmj.b4253
21. Research and practice opportunities at the intersection of health education, health behavior, and genomics. Wang C, Bowen DJ, Kardia SL, Health Educ Behav 2005 32 686 701 10.1177/1090198105278827 16148214 (Pubitemid 41426749)
22. The Genome Gets PersonalAlmost. Feero WG, Guttmacher AE, Collins FS, JAMA 2008 299 1351 1352 10.1001/jama.299.11.1351 18349096 (Pubitemid 351439081)
23. Communicating genetic risk information. Marteau TM, Br Med Bull 1999 55 414 428 10.1258/0007142991902466 10723866 (Pubitemid 29415551)
24. Self-regulation and the behavioural response to DNA risk information: A theoretical analysis and framework for future research. Marteau TM, Weinman J, Social Sci Med 2006 62 1360 1368 10.1016/j.socscimed.2005.08.005 (Pubitemid 43204245)
25. Impact of communicating personalized genetic risk information on perceived control over the risk: a systematic review. Collins RE, Wright AJ, Marteau TM, Genet Med 2011 13 273 10.1097/GIM.0b013e3181f710ca 20921892
26. What does "a gene for heart disease" mean? A focus group study of public understandings of genetic risk factors. Bates BR, Templeton A, Achter PJ, Harris TM, Condit CM, Am J Med Genet A 2003 119A 156 161 10.1002/ajmg.a.20113 12749055 (Pubitemid 37063885)
27. Protection motivation theory. Boer H, Seydel E, Predicting Health Behavior 1st edition Open University Press, Buckingham, Connor M, Norman P, 1996 95 118
28. Risk perceptions and their relation to risk behavior. Brewer N, Weinstein N, Cuite C, Herrington J, Ann Behav Med 2004 27 125 130 10.1207/ s15324796abm2702-7 15026296 (Pubitemid 38364892)
29. Treating people with information: an analysis and review of approaches to communicating health risk information. Rothman AJ, Kiviniemi MT, J Natl Cancer Inst Monogr 1999 1999 44 51 10.1093/oxfordjournals.jncimonographs.a024207
30. What does it mean to understand a risk? Evaluating risk comprehension. Weinstein ND, J Natl Cancer Inst Monogr 1999 1999 15 20 10.1093/oxfordjournals. jncimonographs.a024192
31. Risk communication: Why, what and how?A discussion of the evidence regarding risk communication and how best to do it in practice. Price H, Diabetes and Primary Care 2010 12 100
32. How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: Systematic review. Sivell S, Elwyn G, Gaff CL, Clarke AJ, Iredale R, Shaw C, Dundon J, Thornton H, Edwards A, J Genet Couns 2008 17 30 63 10.1007/s10897-007-9132-1 17968638 (Pubitemid 351230515)
33. Explaining risks: turning numerical data into meaningful pictures. Edwards A, Elwyn G, Mulley A, Br Med J 2002 324 827 830 10.1136/bmj.324.7341.827 (Pubitemid 34280736)
34. Simple tools for understanding risks: from innumeracy to insight. Gigerenzer G, Edwards A, Br Med J 2003 327 741 744 10.1136/bmj.327.7417.741 (Pubitemid 37176763)
35. Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. Cameron LD, Sherman KA, Marteau TM, Brown PM, Heal Psychol 2009 28 307
36. The common-sense model of self-regulation of health and illness. Leventhal H, Brissette I, Leventhal EA, The self-regulation of health and illness behaviour Routledge, New York, Cameron LD, Leventhal H, 2003 42 65
37. A meta-analysis of research on protection motivation theory. Floyd D, Prentice-Dunn S, J Appl Soc Psychol 2000 30 407 429 10.1111/j.1559-1816.2000. tb02323.x
38. Prediction and intervention in health-related behavior: A meta-analytic review of protection motivation theory. Milne S, Sheeran P, Orbell S, J Appl Soc Psychol 2000 30 106 143 10.1111/j.1559-1816.2000.tb02308.x
39. Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Marteau TM, French DP, Griffin SJ, Prevost A, Sutton S, Watkinson C, Attwood S, Hollands GJ, Annu Rev Public Health 2010
40. The behavioral response to personalized genetic information: Will genetic risk profiles motivate individuals and families to choose more healthful behaviors? McBride CM, Koehly LM, Sanderson SC, Kaphingst KA, Annu Rev Public Health 2010 31 89 103 10.1146/annurev.publhealth.012809.103532 20070198
41. Genetic risk and behavioural change. Marteau TM, Lerman C, Br Med J 2001 322 1056 1059 10.1136/bmj.322.7293.1056 (Pubitemid 32396425)
42. Risk reduction and health promotion behaviors following genetic testing for adult-onset disorders. Beery TA, Williams JK, Genet Test 2007 11 111 123 10.1089/gte.2006.0527 17627380 (Pubitemid 47041927)
43. A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Heshka JT, Palleschi C, Howley H, Wilson B, Wells PS, Genet Med 2008 10 19 32 10.1097/GIM.0b013e31815f524f 18197053
44. Delivery of genomic medicine for common chronic adult diseases: a systematic review. Scheuner MT, Sieverding P, Shekelle PG, JAMA 2008 299 1320 1334 10.1001/jama.299.11.1320 18349093 (Pubitemid 351439078)
45. Point: genetic risk feedback for common disease time to test the waters. McBride CM, Brody LC, Cancer Epidemiol Biomarkers Prev 2007 16 1724 1726 10.1158/1055-9965.EPI-07-0102 17855688 (Pubitemid 47450500)
46. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L, Genet Med 2007 9 665 10.1097/GIM.0b013e31815699d0 18073579 (Pubitemid 350287151)
47. Association between birth weight and visceral fat in adults. De Lucia Rolfe E, Loos RJF, Druet C, Stolk RP, Ekelund U, Griffin SJ, Forouhi NG, Wareham NJ, Ong KK, Am J Clin Nutr 2010 92 347 10.3945/ajcn.2010.29247 20519560
48. Interventions to improve risk communication in clinical genetics: Systematic review. Edwards A, Gray J, Clarke A, Dundon J, Elwyn G, Gaff C, Hood K, Iredale R, Sivell S, Shaw C, Thornton H, Patient Educ Counseling 2008 71 4 25 10.1016/j.pec.2007.11.026
49. If Im better than average, then Im ok?: Comparative information influences beliefs about risk and benefits. Fagerlin A, Zikmund-Fisher BJ, Ubel PA, Patient Educ Counseling 2007 69 140 144 10.1016/j.pec.2007.08.008 (Pubitemid 350051684)
50. Perceptions of absolute versus relative differences between personal and comparison health risk. Mason D, Prevost AT, Sutton S, Heal Psychol 2008 27 87
51. Can our health behaviour models handle imagery-based processes and communications? Cameron LD, The Eur Health Psychologist 2009 11 56 58
52. Navigenics, The science behind the Navigenics service [ http://www.navigenics.com/static/pdf/Navigenics-TheScience.pdf ]
53. deCODEme, Risk calculations [ http://demo.decodeme.com/health-watch- information/risk-calculation ]
54. 23andMe, (White Paper 23-01) Estimating genotype-specific incidence for one or several loci [ https://23andme.https.internapcdn.net/res/pdf/HIC- SXIYiYqXreldAxO5yA-23-01-Estimating-Genotype-Specific-Incidence.pdf ] 23032107
55. Lifetime Risk for Diabetes Mellitus in the United States. Narayan KMV, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF, JAMA 2003 290 1884 1890 10.1001/jama.290.14.1884 14532317 (Pubitemid 37430605)
56. NHLBI Obesity Education Initiative Expert Panel on the Identification Evaluation and Treatment of Obesity in Adults, Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - The evidence report National Institutes of Health, Washington DC 1998 18855517
57. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Griffin S, Little P, Hales C, Kinmonth A, Wareham N, Diabetes Metab Res Rev 2000 16 164 171 10.1002/1520-7560(200005/06)16:3<164::AID- DMRR103>3.0.CO;2-R 10867715 (Pubitemid 30410271)
58. A simple risk score identifies individuals at high risk of developing Type 2 diabetes: a prospective cohort study. Rahman M, Simmons RK, Harding AH, Wareham NJ, Griffin SJ, Fam Pract 2008 25 191 196 10.1093/fampra/cmn024 18515811 (Pubitemid 351965938)
59. DOH, At least five a week: Evidence on the impact of physical activity and its relationship to health London Department of Health, London 2004
60. Cardiovascular Review Group Committee on Medical Aspects of Food Policy, Nutritional aspects of cardiovascular disease: Report on health and social subjects HMSO, London 1994
61. Reliability and validity of the combined heart rate and movement sensor Actiheart. Brage S, Brage N, Franks P, Ekelund U, Wareham N, Eur J Clin Nutr 2005 59 561 570 10.1038/sj.ejcn.1602118 15714212 (Pubitemid 40528670)
62. Hierarchy of individual calibration levels for heart rate and accelerometry to measure physical activity. Brage S, Ekelund U, Brage N, Hennings MA, Froberg K, Franks PW, Wareham NJ, J Appl Physiol 2007 103 682 10.1152/japplphysiol.00092.2006 17463305 (Pubitemid 47204988)
63. Branched equation modeling of simultaneous accelerometry and heart rate monitoring improves estimate of directly measured physical activity energy expenditure. Brage S, Brage N, Franks P, Ekelund U, Wong M, Andersen L, Froberg K, Wareham N, J Appl Physiol 2004 96 343 12972441
64. Assessment of low-to-moderate intensity physical activity thermogenesis in young adults using synchronized heart rate and accelerometry with branched-equation modeling. Thompson D, Batterham A, Bock S, Robson C, Stokes K, J Nutr 2006 136 1037 16549471
65. Integration of physiological and accelerometer data to improve physical activity assessment. Strath SJ, Brage S, Ekelund U, Med Sci Sports Exercise 2005 37 563 S571 10.1249/01.mss.0000185650.68232.3f (Pubitemid 41691819)
66. Relation of misperception of healthy weight to obesity in urban black men. Godino JG, Lepore SJ, Rassnick S, Obesity 2009 18 1318 1322 19876006
67. Weight status and perception barriers to healthy physical activity and diet behavior. Atlantis E, Barnes EH, Ball K, Int J Obes 2008 32 343 352 10.1038/sj.ijo.0803707 (Pubitemid 351271775)
68. Do you see what I see? Weight status misperception and exposure to obesity among children and adolescents. Maximova K, McGrath JJ, Barnett T, O'Loughlin J, Paradis G, Lambert M, Int J Obes 2008 32 1008 1015 10.1038/ijo.2008.15 (Pubitemid 351986219)
69. Misconceptions of fruit and vegetable consumption: Differences between objective and subjective estimation of intake. Lechner L, Brug J, De Vries H, J Nutr Educ 1997 29 313 320 10.1016/S0022-3182(97)70245-0
70. Stages of change for fruit, vegetable and fat intake: consequences of misconception. Lechner L, Brug J, De Vries H, van Assema P, Mudde A, Heal Educ Res 1998 13 1-a 11
71. Factors related to misperception of physical activity in The Netherlands and implications for health promotion programmes. Lechner L, Bolman C, Van Dijke M, Heal Promot Int 2006 21 104 112 10.1093/heapro/dal011 (Pubitemid 43828719)
72. A cross-sectional study of awareness of physical activity: associations with personal, behavioral and psychosocial factors. van Sluijs E, Griffin S, van Poppel M, Int J Behav Nutr Phys Act 2007 4 53 10.1186/1479-5868-4-53 17996060
73. The brief illness perception questionnaire. Broadbent E, Petrie KJ, Main J, Weinman J, J Psychosom Res 2006 60 631 637 10.1016/j.jpsychores.2005.10.020 16731240 (Pubitemid 43786439)
74. Lay perceptions of serious illnesses: An adapted version of the Revised Illness Perception Questionnaire (IPQ-R) for healthy people. Figueiras MJ, Alves NC, Psychol Heal 2007 22 143 158 10.1080/14768320600774462
75. Illness risk representations and motivations to engage in protective behavior: The case of skin cancer risk. Cameron LD, Psychol Heal 2008 23 91 112 10.1080/14768320701342383
76. The theory of planned behavior. Ajzen I, Organ Behav Hum Decis Process 1991 50 179 211 10.1016/0749-5978(91)90020-T
77. Constructing a TpB questionnaire: Conceptual and methodological considerations. Ajzen I, aa aa aa a http://socgeo.ruhosting.nl/html/files/ spatbeh/tpb.measurement.pdf
78. Does the theory of planned behavior identify diabetes-related cognitions for intention to be physically active and eat a healthy diet? Blue CL, Public Health Nursing 2007 24 141 150 10.1111/j.1525-1446.2007.00618.x 17319886
79. Scales for assessing perceptions of health hazard susceptibility. Diefenbach MA, Weinstein ND, O'Reilly J, Heal Educ Res 1993 8 181 192 10.1093/her/8.2.181 (Pubitemid 23185822)
80. Relationships among breast cancer perceived absolute risk, comparative risk, and worries. Lipkus IM, Kuchibhatla M, McBride CM, Bosworth HB, Pollak KI, Siegler IC, Rimer BK, Cancer Epidemiol Biomarkers Prev 2000 9 973 975 11008917
81. Understanding self-rated health. Fayers PM, Sprangers MAG, Lancet 2002 359 187 188 10.1016/S0140-6736(02)07466-4 11812551 (Pubitemid 34113813)
82. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. Watson M, Lloyd S, Davidson J, Meyer L, Eeles R, Ebbs S, Murday V, Br J Cancer 1999 79 868 10.1038/sj.bjc. 6690139 10070883 (Pubitemid 29082119)
83. Illness perceptions and distress in women at increased risk of breast cancer. Rees G, Fry A, Cull A, Sutton S, Psychol Heal 2004 19 749 765 10.1080/08870440412331279764 (Pubitemid 40004499)
84. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Marteau TM, Bekker H, Br J Clin Psychol 1992 31 301 306 10.1111/j.2044-8260.1992.tb00997.x 1393159
85. Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice. Park P, Simmons RK, Prevost AT, Griffin SJ, BMC Publ Health 2008 8 350 10.1186/1471-2458-8-350
86. A comparison of direct vs. selfreport measures for assessing height, weight and body mass index: a systematic review. Gorber SC, Tremblay M, Moher D, Gorber B, Obes Rev 2007 8 307 326 10.1111/j.1467-789X.2007.00347.x 17578381 (Pubitemid 46944496)
87. Use of biological markers to validate self-reported dietary intake in a random sample of the European Prospective Investigation into Cancer United Kingdom Norfolk cohort. McKeown NM, Day NE, Welch AA, Runswick SA, Luben RN, Mulligan AA, McTaggart A, Bingham SA, Am J Clin Nutr 2001 74 188 196 11470719 (Pubitemid 32702484)
88. Comparison of dietary assessment methods in nutritional epidemiology: weighed records v. 24h recalls, food-frequency questionnaires and estimated-diet records. Bingham SA, Gill C, Welch A, Day K, Cassidy A, Khaw KT, Sneyd MJ, Key TJA, Roe L, Day NE, Br J Nutr 1994 72 619 643 10.1079/BJN19940064 7986792 (Pubitemid 24317368)
89. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR, Br Med J 2009 338 2393 10.1136/bmj.b2393
90. Adjusting for partially missing baseline measurements in randomized trials. White IR, Thompson SG, Stat Med 2005 24 993 1007 10.1002/sim.1981 15570623 (Pubitemid 40426000)
91. Randomised controlled trial of the effects of physical activity feedback on awareness and behaviour in UK adults: the FAB study protocol [ISRCTN92551397]. Watkinson C, van Sluijs E, Sutton S, Marteau T, Griffin S, BMC Publ Health 2010 10 144 10.1186/1471-2458-10-144
92. ICH harmonised tripartite guideline, Guideline for good clinical practice E6 (R1) [ http://www.ich.org/fileadmin/Public-Web-Site/ICH-Products/Guidelines/ Efficacy/E6-R1/Step4/E6-R1-Guideline.pdf ]
93. Developing and evaluating complex interventions: the new Medical Research Council guidance. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, Br Med J 2008 337 1655 10.1136/bmj.a1655
94. Preventing type 2 diabetes: can we make the evidence work? Yates T, Davies M, Khunti K, Postgrad Med J 2009 85 475 480 10.1136/pgmj.2008.076166 19734515